Transcutaneous pacing: Patient tolerance, strength-interval relations and feasibility for programmed electrical stimulation

Lawrence S. Klein, William M. Miles, James J. Heger, Douglas P. Zipes

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Noninvasive transcutaneous pacing has been used successfully in situations requiring emergent ventricular pacing,1-8 and has also been used to terminate ventricular (VT) or supraventricular tachycardia in some patients.9-13 Thus, transcutaneous pacing might logically be considered a suitable noninvasive substitute for endocardial pacing during programmed electrical stimulation studies. We therefore determined the following features of transcutaneous pacing using the Zoll noninvasive temporary pacemaker (Zoll NTP, ZMI Corp.): patient tolerance, which cardiac chambers were paced, the ventricular effective refractory period (ERP) compared with that determined by endocardial pacing and feasibility for programmed electrical stimulation in patients with ventricular tachyarrhythmias.

Original languageEnglish (US)
Pages (from-to)1126-1129
Number of pages4
JournalThe American journal of cardiology
Volume62
Issue number16
DOIs
StatePublished - Nov 15 1988

Fingerprint

Electric Stimulation
Supraventricular Tachycardia
Ventricular Tachycardia
Tachycardia

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Transcutaneous pacing : Patient tolerance, strength-interval relations and feasibility for programmed electrical stimulation. / Klein, Lawrence S.; Miles, William M.; Heger, James J.; Zipes, Douglas P.

In: The American journal of cardiology, Vol. 62, No. 16, 15.11.1988, p. 1126-1129.

Research output: Contribution to journalArticle

Klein, Lawrence S. ; Miles, William M. ; Heger, James J. ; Zipes, Douglas P. / Transcutaneous pacing : Patient tolerance, strength-interval relations and feasibility for programmed electrical stimulation. In: The American journal of cardiology. 1988 ; Vol. 62, No. 16. pp. 1126-1129.
@article{f72c27892eac44db9579352e7bd6ad71,
title = "Transcutaneous pacing: Patient tolerance, strength-interval relations and feasibility for programmed electrical stimulation",
abstract = "Noninvasive transcutaneous pacing has been used successfully in situations requiring emergent ventricular pacing,1-8 and has also been used to terminate ventricular (VT) or supraventricular tachycardia in some patients.9-13 Thus, transcutaneous pacing might logically be considered a suitable noninvasive substitute for endocardial pacing during programmed electrical stimulation studies. We therefore determined the following features of transcutaneous pacing using the Zoll noninvasive temporary pacemaker (Zoll NTP, ZMI Corp.): patient tolerance, which cardiac chambers were paced, the ventricular effective refractory period (ERP) compared with that determined by endocardial pacing and feasibility for programmed electrical stimulation in patients with ventricular tachyarrhythmias.",
author = "Klein, {Lawrence S.} and Miles, {William M.} and Heger, {James J.} and Zipes, {Douglas P.}",
year = "1988",
month = "11",
day = "15",
doi = "10.1016/0002-9149(88)90563-2",
language = "English (US)",
volume = "62",
pages = "1126--1129",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "16",

}

TY - JOUR

T1 - Transcutaneous pacing

T2 - Patient tolerance, strength-interval relations and feasibility for programmed electrical stimulation

AU - Klein, Lawrence S.

AU - Miles, William M.

AU - Heger, James J.

AU - Zipes, Douglas P.

PY - 1988/11/15

Y1 - 1988/11/15

N2 - Noninvasive transcutaneous pacing has been used successfully in situations requiring emergent ventricular pacing,1-8 and has also been used to terminate ventricular (VT) or supraventricular tachycardia in some patients.9-13 Thus, transcutaneous pacing might logically be considered a suitable noninvasive substitute for endocardial pacing during programmed electrical stimulation studies. We therefore determined the following features of transcutaneous pacing using the Zoll noninvasive temporary pacemaker (Zoll NTP, ZMI Corp.): patient tolerance, which cardiac chambers were paced, the ventricular effective refractory period (ERP) compared with that determined by endocardial pacing and feasibility for programmed electrical stimulation in patients with ventricular tachyarrhythmias.

AB - Noninvasive transcutaneous pacing has been used successfully in situations requiring emergent ventricular pacing,1-8 and has also been used to terminate ventricular (VT) or supraventricular tachycardia in some patients.9-13 Thus, transcutaneous pacing might logically be considered a suitable noninvasive substitute for endocardial pacing during programmed electrical stimulation studies. We therefore determined the following features of transcutaneous pacing using the Zoll noninvasive temporary pacemaker (Zoll NTP, ZMI Corp.): patient tolerance, which cardiac chambers were paced, the ventricular effective refractory period (ERP) compared with that determined by endocardial pacing and feasibility for programmed electrical stimulation in patients with ventricular tachyarrhythmias.

UR - http://www.scopus.com/inward/record.url?scp=0023734448&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023734448&partnerID=8YFLogxK

U2 - 10.1016/0002-9149(88)90563-2

DO - 10.1016/0002-9149(88)90563-2

M3 - Article

C2 - 3189176

AN - SCOPUS:0023734448

VL - 62

SP - 1126

EP - 1129

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 16

ER -